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Abstract
Background: Primary diffuse large B cell lymphoma (DLBCL) of the uterus is rare, and primary DLBCL arising from a
uterine leiomyoma (collision tumor) has not been reported in the literature.
Case presentation: We describe the clinical, histological, immunohistochemical, and molecular features of primary
DLBCL arising from a leiomyoma in the uterine corpus. A 73-year-old female patient had a uterine mass for
23 years. An ultrasound scan revealed marked enlargement of the uterus, measuring 18.2 × 13 × 16.3 cm, with a
17.6 × 10.9 × 11.6 cm hypoechoic mass in the uterine corpus. The tumors consisted of medium- to large-sized cells
exhibiting a diffuse pattern of growth with a well-circumscribed leiomyoma. The neoplastic cells strongly expressed
CD79α, CD20 and PAX5. Molecular analyses indicated clonal B-cell receptor gene rearrangement.
Conclusions: To the best of our knowledge, no previous cases of primary DLBCL arising from a leiomyoma have
been reported. It is necessary to differentiate a diagnosis of primary DLBCL arising from a leiomyoma from that of
leiomyoma with florid reactive lymphocytic infiltration (lymphoma-like lesion). Careful analysis of clinical,
histological, immunophenotypic, and genetic features is required to establish the correct diagnosis.
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Background
Primary lymphoma of the uterus is rare and diffuse large
B cell lymphoma (DLBCL) is the most common histo-
logical subtype [1, 2]. However, primary DLBCL arising
from the uterine leiomyoma has not been reported in
the literature. We describe, for the first time, a collision
tumor consisting of DLBCL and leiomyoma of the
uterus in a 73-year-old female patient. To the best of
our knowledge, no previous report has described the
concurrence of these two types of tumors in any other
tissues or organs.
Case presentation
A 73-year-old woman had a uterine mass for 23 years
without abnormal vaginal bleeding or discharge. A sono-
graphic examination performed 23 years prior showed a
myomatous mass that measured approximately 7 cm (as
described by the patient; no ultrasound report was avail-
able). The patient did not complain of discomfort and
did not undergo a Pap smear or medical treatment
during this 23-year period. One year ago, the patient
underwent a gynecological B ultrasound examination,
which revealed that the uterine mass had enlarged since
the previous sonogram (as described by the patient; no
ultrasound report was available). The more recent ultra-
sound scan revealed marked enlargement of the uterus,
measuring 18.2 × 13 × 16.3 cm, with a 17.6 × 10.9 ×
11.6 cm hypoechoic mass in uterine corpus. This mass
was nonhomogeneous and had irregular borders. The
cervical thickness was 2 cm and had homogeneous
echogenicity. The endometrial thickness was 3 mm. Bi-
lateral adnexa were not clearly delineated. The mass was
diagnosed as a leiomyoma by ultrasound. Laboratory
tests revealed that the serum CA-153 level was 39.93 U/
ml (high), the β2-microglobulin level was 3.24 mg/L
(high), and the serum lactate dehydrogenase level and
other biochemical test results were normal. The
complete blood cell count revealed a white blood cell
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count of 6.4×109 /L, a hemoglobin level of 123 g/L, and
a platelet count of 186×109/L. The Pap smear results
showed moderate inflammation and no other abnormal-
ities. Intraoperatively, a well-defined intramural myoma
was observed in the anterior wall of the uterine fundus
(The surgeon opened the uterus but did not collect a
sample during the surgery for generation of frozen sec-
tions), and hysterectomy and bilateral adnexectomy were
performed. The postoperative course of the patient was
uneventful. The patient underwent no further examin-
ation or treatment due to economic reasons. At the
most recent follow-up (13 months after the diagnosis),
the patient was alive and did not report any discomfort.
On gross examination, the uterine corpus was com-
pletely replaced by a whorled intramural single mass
with a diameter of 17 cm, and the cut surface appeared
yellowish with focal hemorrhage, without any necrosis
or calcification. The endometrium was smooth and had
a thickness of 3 mm. The cervix and bilateral adnexa
displayed no abnormalities. The mass was sampled by
examining 2 sections /cm. Histological examination of
the formalin-fixed, paraffin-embedded sections revealed
a marked, predominantly lymphocytic infiltrate involv-
ing a well-circumscribed leiomyoma, and a few lym-
phocytes extended into the adjacent myometrium with
an intravascular tumor thrombus. Within the leio-
myoma without any mitosis or necrosis, the lymphoid
infiltrate was diffuse, and there were only a few
recognizable whorled bundles and fascicles of smooth-
muscle cells (Fig. 1a). The lymphoid cells consisted of
medium- to large-sized cells with abundant, faintly
basophilic cytoplasm and round to oval nuclei, which
were sometimes convoluted and which contained dis-
persed nuclear chromatin and one to multiple promin-
ent nucleoli (Fig. 1b). Mitoses were frequent. In the
background, infiltration of a few small lymphocytes was
observed. Most of the lymphoid cells were positive for
CD79α, CD20 (Fig. 2a), PAX5 (Fig. 2b), bcl-2 and
MUM-1 but negative for CD3, CD5, CD4, CD8, CD10,
bcl-6, CD56, CD30, CD21, CD23, CD138, perforin and
Gram β. The proliferative index (based on Ki-67 stain-
ing) was high (approximately 50 %) (Fig. 2c). Smooth-
muscle cells were positive for desmin and caldesmon
(Fig. 2d). To determine the clonality of the lymphocytic
infiltrate at the Ig receptor level, immunoglobulin heavy
chain gene rearrangement was evaluated. Via polymer-
ase chain reaction (PCR) and subsequent capillary gel
electrophoresis, the suspected monoclonal nature of
the infiltrate was confirmed.
The tumor was ultimately diagnosed as a stage IE (Ann
Arbor) primary DLBCL of the activated B-cell-like (ABC)
subtype arising from the uterine leiomyoma (collision
tumor).
Discussion
Although infiltration of the uterus during the course
of malignant lymphoma is not rare, few malignant
lymphomas originate in the uterus. In a study with a
large number of cases, it was reported that malignant
lymphomas originating in the uterus accounted for
0.5 % of all extranodal lymphomas and that they were
most common in the cervical region. The histological
type of these tumors was DLBCL [1, 2]. Even when the
uterus is the main clinical lesion site, it is difficult to
determine whether the uterus is the primary site or a
site of infiltration in an advanced stage [1, 2]. The cri-
teria for assessing the primacy of a DLBCL are de-
signed such that the diagnosis is only correct if the
disease is confined to the organ and if there are no
signs of DLBCL in other organs at diagnosis or during
follow-up [1, 2]. Although a complete CT or PET scan
was not available, our case did not progress during a
follow-up period of greater than year without receiv-
ing any therapy; as a result, this case may be consid-
ered as a diagnosis of primary DLBCL.
Fig. 1 Histological features of primary DLBCL arising from a leiomyoma of the uterine corpus. Diffuse proliferation of lymphoid cells dissecting
the muscle fiber is observed (a). Lymphoid cells consist of medium- to large-sized cells with abundant, faintly basophilic cytoplasm and round to
oval nuclei, which are occasionally convoluted and which contain dispersed nuclear chromatin and one to multiple prominent nucleoli (b). [A-B:
hematoxylin and eosin (H & E) staining; A: original magnification (O.M.), 100×; B: O.M., 200×]
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One peculiarity of this case was the coexistence of
DLBCL and leiomyoma. In previous reports, cases of
primary T-cell lymphoma arising from a leiomyoma of
the uterus was described, and these tumors expressed T-
cell antigens (CD3 and CD8) and markers of cytotoxicity
(TIA and granzyme) and exhibited monoclonal re-
arrangement of the T-cell receptor based on molecular
analyses [3]. Our case, however, expressed B-cell anti-
gens (CD20, PAX5 and CD79α) but not markers of T-
cells or cytotoxicity. Molecular analyses revealed clonal
B-cell receptor gene rearrangement (immunoglobulin
heavy chain gene rearrangement). Therefore, this is the
first case of a proven primary DLBCL arising from a
leiomyoma in the uterine corpus.
The most important differential diagnoses in this case
included leiomyoma with heavy lymphocytic infiltration
and massive lymphoid infiltration simulating lymphoma
(lymphoma-like lesion) [4–7]. Regarding the previously
reported lesions, the leiomyoma contained a variably
dense infiltrate consisting of small lymphocytes, scat-
tered larger lymphoid cells, and, occasionally, numerous
plasma cells. Germinal centers were identified in some
cases and ranged from large and florid to inconspicuous.
Lymphoid infiltration was confined to the leiomyoma or
was present to only a minor extent in the adjacent myo-
metrium. Immunohistochemical findings were positive
for desmin and leukocyte common antigen and demon-
strated a positive reactivity for B-cell and T-cell markers.
Additionally, the proportions of B and T cells were
nearly equal, and there was no preponderance of either
lymphoid cell type [4–7]. In our case, the lymphoid
infiltrate extended into the adjacent myometrium and
included an intravascular tumor thrombus. Immunohis-
tochemistry showed a preponderance of the B-cell type,
and molecular analyses provided evidence for clonal B-
cell receptor gene rearrangement. Therefore, we defined
the pathological diagnosis as primary DLBCL arising
from a leiomyoma. It must be emphasized, however, that
florid reactive lymphoid hyperplasia (lymphoma-like le-
sion) may exhibit clonal IGH gene rearrangement based
on PCR [8]. Therefore, it is essential to comprehensively
analyze clinical, histologic, immunophenotypic, and gen-
etic features to establish the correct diagnosis.
Because our case had a history of 23 years, it may be
hypothesized that the DLBCL evolved as a result of pro-
gression from a polyclonal inflammatory population
concomitant with the development of a leiomyoma with
lymphocytic infiltration or massive lymphoid infiltration,
resulting in a collision tumor. However, there is a lack of
strong evidence supporting this assumption.
Conclusions
We report the first documented case of DLBCL concur-
rent with leiomyoma in the uterus. Although these find-
ings could be purely coincidental, it should be considered
that there might be a causal relationship between DLBCL
and leiomyoma with lymphocytic infiltration. We could
not exclude the possibility that the leiomyoma induced a
lymphoid reaction with an extranodal lymphoma, repre-
senting the final event of progression of the inflammatory
reaction.
Fig. 2 Immunohistochemical findings of primary DLBCL arising from a leiomyoma of the uterine corpus. Most lymphoid cells are positive for
CD20 (a) and PAX5 (b). The proliferative index is high (approximately 50 %) (c). Smooth-muscle cells are positive for caldesmon (d). (A: CD20 stain,
B: PAX5 stain, C: Ki-67 stain, D: caldesmon stain; A, B: O.M., 200×; C, D: O.M., 100×)
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Consent
Written informed consent was obtained from the patients
for publication of this Case Report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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